甲状腺功能亢进症的中西医结合干预现状与展望

Current Status and Prospects of Integrated Traditional Chinese and Western Medicine Interventions for Hyperthyroidism

摘要: 甲状腺功能亢进症是内分泌系统的常见病、多发病，以甲状腺激素分泌过多为主要特征。目前西医治疗甲亢疗效确切，但存在药物副作用、复发率较高等问题。中医对甲亢的认识可追溯至《黄帝内经》“多食而瘦”、“颈前肿大”的记载，属中医“瘿病”“瘿气”范畴。强调本病以阴虚为本、气滞痰凝血瘀为标。中医在改善症状、减少复发方面具有独特优势。近年来，中西医结合干预通过优势互补，在提升疗效、减少副作用、降低复发率等方面展现显著价值，其临床应用现状与发展前景值得深入探讨。本文系统综述了甲亢的中西医结合干预现状，分析了其作用机制与临床价值，并针对当前研究的不足，对未来发展方向进行展望，以期为该领域的深入研究与临床实践提供参考。

Abstract: Mon is a frequently occurring disease of the endocrine system, characterized primarily by excessive secretion of thyroid hormones. Currently, Western medicine offers effective treatments for hyperthyroidism, but issues such as drug side effects and high recurrence rates persist. The understanding of hyperthyroidism in Traditional Chinese Medicine (TCM) can be traced back to the “Inner Canon of Huangdi”, which documented symptoms like “excessive eating with weight loss” and “swelling in the neck”, classifying it under the TCM categories of “goiter disease” and “goiter qi”. TCM emphasizes that the root cause of this condition lies in yin deficiency, while qi stagnation, phlegm coagulation, and blood stasis serve as secondary factors. TCM possesses unique advantages in symptom improvement and recurrence reduction. In recent years, integrated Chinese-Western medicine interventions have demonstrated significant value in enhancing efficacy, reducing side effects, and lowering recurrence rates through complementary strengths. The current clinical application status and development prospects of such interventions warrant in-depth exploration. This paper systematically reviews the current state of integrated Chinese-Western medicine interventions for hyperthyroidism, analyzes their mechanisms of action and clinical value, and proposes future research directions to address existing gaps, aiming to provide references for further research and clinical practice in this field.